Search / Trial NCT06614829

Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO)

Launched by NORTH YORK GENERAL HOSPITAL · Sep 24, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called CS-PREO, is looking at two different ways to close the wound after a cesarean section (C-section) to see which method works better for patients. One group of patients will receive the standard method of wound closure, while the other group will use a new combination of Stratafix sutures and Dermabond PRINEO, which is a special adhesive. The goal is to understand how these two methods compare in terms of recovery and any complications, such as infections.

Women aged 18 and older who are planning to have an elective C-section between 13 to 36 weeks of pregnancy may be eligible to participate. Participants will need access to the internet or a smartphone to fill out questionnaires about their experiences after the surgery. It's important to note that the study materials are only available in English, and participants must be covered by the Ontario Health Insurance Plan. If you are considering joining this study, you can expect to share your experiences and outcomes, which will help improve care for future C-section patients.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patient must be 18 years of age or older at time of recruitment
  • 2. Patients opting for a planned (elective) C-Section (13-36 weeks gestation) will be eligible to consent.
  • 3. Patients must have internet access and/or a smartphone in order to access the digital platform to complete the study questionnaires
  • 4. Patients must speak and write in English as study questionnaires will only be provided in English
  • 5. Patients must have coverage from the Ontario Health Insurance Plan (OHIP)
  • Exclusion Criteria:
  • 1. Patients assessed by the participating surgeon with any conditions that may compromise their:
  • Ability to consent or use the virtual care platform (e.g., patients with intellectual disabilities)
  • Expectation of significant maternal complications that may affect the surgery
  • 2. Patients who enroll in the study but have an unplanned emergency C-section

About North York General Hospital

North York General Hospital is a leading community hospital in Toronto, Canada, renowned for its commitment to providing high-quality patient care and advancing medical research. As a sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to facilitate innovative research initiatives aimed at improving health outcomes. By fostering collaboration among healthcare professionals, researchers, and academic institutions, North York General Hospital plays a pivotal role in translating scientific discoveries into effective clinical practices, ultimately enhancing patient care and contributing to the advancement of medical knowledge.

Locations

North York, Ontario, Canada

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0